|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1124925200 |
| 003 |
OCoLC |
| 005 |
20231120010417.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
191024t20202020enka ob 000 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d OCLCF
|d N$T
|d SFB
|d OCLCO
|d OCLCA
|d INM
|d MMU
|d USU
|d OCLCO
|d OPELS
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d CASUM
|d CNCNC
|d OCLCO
|
| 019 |
|
|
|a 1152065944
|
| 020 |
|
|
|a 9780128122426
|q (electronic bk.)
|
| 020 |
|
|
|a 0128122420
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128121023
|q (print)
|
| 020 |
|
|
|z 0128121025
|q (print)
|
| 035 |
|
|
|a (OCoLC)1124925200
|z (OCoLC)1152065944
|
| 050 |
|
4 |
|a RC600
|
| 060 |
|
4 |
|a QW 545
|
| 082 |
0 |
4 |
|a 616.978
|2 23
|
| 130 |
0 |
|
|a Autoimmune diseases (Rose)
|
| 245 |
1 |
4 |
|a The autoimmune diseases /
|c edited by Noel R. Rose, Ian R. Mackay.
|
| 250 |
|
|
|a Sixth edition.
|
| 264 |
|
1 |
|a London :
|b Academic Press,
|c [2020]
|
| 264 |
|
4 |
|c �2020
|
| 300 |
|
|
|a 1 online resource :
|b illustrations (chiefly color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
|
|a Autoimmune disease: reflections and projections -- Autoimmunity: a history of the early struggle for recognition -- General features of autoimmune disease -- Innate and adaptive systems of immunity -- Immunological tolerance: T cells -- T cells and their subsets in autoimmunity -- The role of invariant natural killer T cells in autoimmune diseases -- B-cell development: how to become one of the chosen ones -- B cell activation and b cell tolerance -- Macrophages and autoimmunity -- Dendritic cells in autoimmune disease -- Natural killer cells -- Granulocytes: neutrophils, basophils, eosinophils -- The roles and contributions of the complement system in the pathophysiology of autoimmune diseases -- Cytokines, their receptors and signals -- Cell death and autoimmune disease -- Autophagy in autoimmunity -- Effector mechanisms in autoimmunity -- Diet, the gut microbiome, and autoimmune diseases -- Noninfectious environmental agents and autoimmunity -- Microbial infection as a trigger of T-cell autoimmunity -- Autoimmune diseases: the role for vaccines -- Genetic predisposition, humans -- Sexual dimorphism in the immune system -- Epigenetics of autoimmune diseases -- Genetic predisposition to autoimmune diseases conferred by the major histocompatibility complex: utility of animal models -- Animal models of organ-specific autoimmune disease -- Autoimmunity in primary immunodeficiency disorders -- Animal models: systemic autoimmune diseases -- Systemic lupus erythematosus -- Systemic sclerosis (scleroderma) -- Antiphospholipid syndrome -- Sjogren's syndrome -- Rheumatoid arthritis -- Juvenile idiopathic arthritis -- Spondyloarthritides -- The autoimmune myopathies -- Immunoglobulin g4-related disease -- Polyendocrine syndromes -- Thyroid disease -- Autoimmune (type 1) diabetes -- Adrenalitis -- Autoimmune hypophysitis -- Autoimmune gastritis and pernicious anemia -- Celiac disease -- Inflammatory bowel disease -- Autoimmune hemolytic anemia -- Immune thrombocytopenia: a complex autoimmune disease
|
| 505 |
8 |
|
|a Acquired aplastic anemia -- Autoimmune clotting dysfunction -- Multiple sclerosis -- Peripheral neuropathies -- Myasthenia gravis and related disorders -- Ocular disease -- Immune-mediated inner ear disease -- Autoimmune and autoantibody-associated encephalomyelopathies -- Hepatitis -- Primary biliary cholangitis -- Autoimmune pancreatitis and immunoglobulin g4-related disease -- Autoimmune bullous skin diseases: pemphigus and pemphigoid -- Nonbullous skin diseases: alopecia areata, vitiligo, psoriasis, and urticaria -- Autoimmune orchitis and autoimmune oophoritis -- Rheumatic fever and rheumatic heart disease -- Myocarditis and dilated cardiomyopathy -- Necrotizing arteritis and small-vessel vasculitis -- Large and medium-vessel vasculitides -- Idiopathic and autoimmune interstitial lung disease -- Autoimmune diseases in the kidney -- Autoantibody assays: performance, interpretation, and standardization -- Prevention of autoimmune disease: the type diabetes paradigm -- Treatment of autoimmune disease: established therapies -- Emerging biological and molecular therapies in autoimmune disease -- Cameos: candidates and curiosities.
|
| 588 |
0 |
|
|a Online resource; title from electronic title page (ClinicalKey, December 21, 2021).
|
| 650 |
|
0 |
|a Autoimmune diseases.
|
| 650 |
|
2 |
|a Autoimmune Diseases
|0 (DNLM)D001327
|
| 650 |
|
6 |
|a Maladies auto-immunes.
|0 (CaQQLa)201-0064242
|
| 650 |
|
7 |
|a Autoimmune diseases
|2 fast
|0 (OCoLC)fst00822663
|
| 655 |
|
0 |
|a Electronic books.
|
| 655 |
|
4 |
|a Internet Resources.
|
| 700 |
1 |
|
|a Rose, Noel R.,
|e editor.
|
| 700 |
1 |
|
|a Mackay, Ian R.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Autoimmune diseases.
|b Sixth edition.
|d Amsterdam : Academic Press, 2019
|z 9780128121023
|w (OCoLC)1122872502
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128121023
|z Texto completo
|
